CERBIOS ANNOUNCES THE FINALIZATION OF A NEW CGMP UNIT FOR CYTOTOXIC MOLECULES
Cerbios-Pharma SA is pleased to announce the completion of its new manufacturing building dedicated to Cytotoxic molecules. The fitting and installation of the equipment that was started in Q2 2022 in the freshly constructed structure, is now…